Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VSTM
Stock Latest News
Ratings
Verastem: Avutometinib Plus Defactinib Data De-Risk Efficacy Thesis; Buy Rating Reiterated With Unchanged $18 Price Target
5m ago
VSTM
Premium
The Fly
Verastem to unveil new clinical data on VS-7375
3d ago
VSTM
Premium
The Fly
Verastem price target lowered to $13 from $14 at Mizuho
1M ago
VSTM
Premium
The Fly
Verastem price target lowered to $13 from $14 at Mizuho
1M ago
VSTM
Premium
Company Announcements
Verastem Earnings Call Highlights Cash, Pipeline Momentum
1M ago
VSTM
Premium
Company Announcements
Verastem Restructures Oberland Financing to Support Commercialization
1M ago
8K
VSTM
Premium
The Fly
Verastem price target lowered to $12 from $14 at Guggenheim
1M ago
VSTM
Premium
Ratings
Verastem Reiterated as Buy on Strong AVMAPKI FAKZYNJA Momentum, VS-7375 Progress; $18 Price Target Maintained
1M ago
VSTM
Premium
The Fly
Verastem reports Q2 adjusted EPS (31c), consensus (44c)
1M ago
VSTM
Premium
Pre-Earnings
Is VSTM a Buy, Before Earnings?
1M ago
VSTM
Premium
Company Announcements
Verastem’s TARGET-D 202 Trial Puts Fresh Focus on KRAS G12D Lung Cancer
1M ago
VSTM
Premium
The Fly
Verastem doses first patients in Target-D 203 Phase 2 trial
1M ago
VSTM
Premium
The Fly
Verastem doses first patient in TARGET-D 202 Phase 2 trial
2M ago
VSTM
Premium
Company Announcements
Verastem’s KRAS G12D Trial Targets a New Niche in Colorectal Cancer
2M ago
VSTM
Premium
The Fly
Citizens healthcare analysts hold an analyst/industry conference call
2M ago
CTMX
EXEL
Premium
The Fly
Verastem price target lowered to $14 from $15 at RBC Capital
2M ago
VSTM
Premium
Company Announcements
Verastem’s RAMP 204 Trial Completion Signals New Momentum in KRAS G12C Lung Cancer
2M ago
VSTM
Premium
Weekend Updates
Cardiff, Verastem, Fluence, Quantum-Si, Opera Insider Shock
3M ago
QSI
CRDF
Premium
Company Announcements
Verastem Advances VS-7375 with Promising Early Trial Data
3M ago
8K
VSTM
Premium
The Fly
Verastem reports ‘positive’ preliminary data from ongoing TARGET-D trial
3M ago
VSTM
Premium
The Fly
Verastem price target lowered to $8 from $15 at Jefferies
3M ago
VSTM
Premium
Company Announcements
Verastem’s KRAS G12D Pancreatic Cancer Trial Advances: What Investors Should Watch
3M ago
VSTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
